Freedom of Information request on individuals with parathesia developing a blood clot following the COVID-19 vaccine (FOI 21/1060)
Published 27 April 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: [email protected].
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-11-october-2021/freedom-of-information-request-on-individuals-with-parathesia-developing-a-blood-clot-following-the-covid-19-vaccine-foi-211060
14th October 2021
FOI 21/1060
Dear
Thank you for your FOI request dated 16th September 2021, where you asked:
“Please could you tell me how many people with parathesia have developed a blot clot after taking the Covid vaccine.
Could you also disclose how many people who have had Covid and how many have developed a blood clot.”
Unfortunately, we are unable to provide details of past medical history for individual cases. Because of the way this information is captured within our database, this would require manual extraction of the information from each individual case. Therefore, this information is exempt from release under Section 12 of the FOI Act. Section 12 of the FOI Act specifies that a public authority may refuse requests where the cost of dealing with them would exceed the appropriate limit, which for central government is set at £600. This represents the estimated cost of one person spending 24 working hours in determining whether the department holds the information, locating, retrieving, and extracting the information. Please be reassured that any information provided regarding a patient’s past medical history or concurrent conditions is taken into account during the routine assessment of all cases that we receive.
With regards to your second question, the MHRA does not hold this information. We suggest you contact Public Health England for this information, please find below contact details;
Email: [email protected]
If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.
Yours sincerely,
FOI Team,
Vigilance and Risk Management of Medicines Division